pixatimod (PG545) / Zucero Therap 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   84 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pixatimod (PG545) / Zucero Therap
NCT05061017: Pixatimod (PG545) Plus Nivolumab in PD-1 Relapsed/Refractory Metastatic Melanoma and NSCLC and With Nivolumab and Low-dose Cyclophosphamide in MSS Metastatic Colorectal Carcinoma (mCRC)

Completed
2
14
US
Pixatimod, (PG545), Nivolumab, OPDIVO®, Cyclophosphamide (low dose)
Diwakar Davar, Aculeus Therapeutics
NSCLC, Metastatic Colorectal Carcinoma, Refractory Melanoma
02/24
03/24

Download Options